$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
慢粒性白血病病变期之急变期
2025-10-19 11:44:20
Check Details
卡博替尼适应症之急性髓细胞白血病
2025-10-19 11:44:20
Check Details
白血病患者服用来那度胺的疗效
2025-10-19 11:44:20
Check Details
达沙替尼的推荐剂量
2025-10-19 11:44:20
Check Details
白血病治疗用药达沙替尼
2025-10-19 11:44:20
Check Details
针对伊马替尼发生耐药后,患者可服用达沙替尼
2025-10-19 11:44:20
Check Details
儿童白血病患者可以服用达沙替尼吗?
2025-10-19 11:44:20
Check Details
青少年白血病患者可以服用达沙替尼
2025-10-19 11:44:20
Check Details
达沙替尼获批治疗哪种白血病患者
2025-10-19 11:44:20
Check Details
达沙替尼治疗白血病儿童患者
2025-10-19 11:44:20
Check Details
伊布替尼和Obinotuzumab联合治疗白血病
2025-10-19 11:44:20
Check Details
白血病靶向药物达沙替尼的用法用量
2025-10-19 11:44:20
Check Details
1
2
...
133
134
135
136
137
138
139
...
934
935
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
2
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
3
Avatrombopag (Doptelet) Dosage: Dose Adjustment and Medication Guidelines for Different Indications
4
Effects of Gilteritinib (Xospata) Discontinuation in Acute Myeloid Leukemia Treatment
5
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia
6
Kresladi Approved by FDA: First Gene Therapy for Severe LAD-I
7
Pegcetacoplan Side Effects and Medication Safety Complete Guide
8
Pegcetacoplan (Empaveli): Complete Guide to PNH Complement Inhibitor Treatment
9
Eltrombopag: Innovative TPO Receptor Agonist for Treating Thrombocytopenia - Comprehensive Drug Analysis
10
Is MDS Targeted Therapy Chemotherapy? Mechanism, Genetic Testing, and Personalized Care Guide
11
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
12
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained